WayPoint Biomedical's market value is the price at which a share of WayPoint Biomedical trades on a public exchange. It measures the collective expectations of WayPoint Biomedical Holdings investors about its performance. WayPoint Biomedical is trading at 3.0E-4 as of the 26th of December 2025. This is a No Change since the beginning of the trading day. The stock's open price was 3.0E-4. With this module, you can estimate the performance of a buy and hold strategy of WayPoint Biomedical Holdings and determine expected loss or profit from investing in WayPoint Biomedical over a given investment horizon. Check out WayPoint Biomedical Correlation, WayPoint Biomedical Volatility and WayPoint Biomedical Alpha and Beta module to complement your research on WayPoint Biomedical.
Please note, there is a significant difference between WayPoint Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if WayPoint Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, WayPoint Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
WayPoint Biomedical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to WayPoint Biomedical's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of WayPoint Biomedical.
0.00
11/26/2025
No Change 0.00
0.0
In 30 days
12/26/2025
0.00
If you would invest 0.00 in WayPoint Biomedical on November 26, 2025 and sell it all today you would earn a total of 0.00 from holding WayPoint Biomedical Holdings or generate 0.0% return on investment in WayPoint Biomedical over 30 days. WayPoint Biomedical Holdings, Inc., through its wholly owned subsidiary, WayPoint Biomedical, Inc., engages in the devel... More
WayPoint Biomedical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure WayPoint Biomedical's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess WayPoint Biomedical Holdings upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for WayPoint Biomedical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as WayPoint Biomedical's standard deviation. In reality, there are many statistical measures that can use WayPoint Biomedical historical prices to predict the future WayPoint Biomedical's volatility.
WayPoint Biomedical is out of control given 3 months investment horizon. WayPoint Biomedical shows Sharpe Ratio of 0.14, which attests that the company had a 0.14 % return per unit of risk over the last 3 months. We were able to interpolate data for eighteen different technical indicators, which can help you to evaluate if expected returns of 17.53% are justified by taking the suggested risk. Use WayPoint Biomedical Holdings Mean Deviation of 66.85, standard deviation of 247.67, and Market Risk Adjusted Performance of (1.64) to evaluate company specific risk that cannot be diversified away. WayPoint Biomedical holds a performance score of 10 on a scale of zero to a hundred. The firm maintains a market beta of -19.49, which attests to a somewhat significant risk relative to the market. As returns on the market increase, returns on owning WayPoint Biomedical are expected to decrease by larger amounts. On the other hand, during market turmoil, WayPoint Biomedical is expected to outperform it. Use WayPoint Biomedical Holdings market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and skewness , to analyze future returns on WayPoint Biomedical Holdings.
Auto-correlation
-0.19
Insignificant reverse predictability
WayPoint Biomedical Holdings has insignificant reverse predictability. Overlapping area represents the amount of predictability between WayPoint Biomedical time series from 26th of November 2025 to 11th of December 2025 and 11th of December 2025 to 26th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of WayPoint Biomedical price movement. The serial correlation of -0.19 indicates that over 19.0% of current WayPoint Biomedical price fluctuation can be explain by its past prices.
Correlation Coefficient
-0.19
Spearman Rank Test
0.5
Residual Average
0.0
Price Variance
0.0
WayPoint Biomedical lagged returns against current returns
Autocorrelation, which is WayPoint Biomedical pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting WayPoint Biomedical's pink sheet expected returns. We can calculate the autocorrelation of WayPoint Biomedical returns to help us make a trade decision. For example, suppose you find that WayPoint Biomedical has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values
Timeline
WayPoint Biomedical regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If WayPoint Biomedical pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if WayPoint Biomedical pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in WayPoint Biomedical pink sheet over time.
Current vs Lagged Prices
Timeline
WayPoint Biomedical Lagged Returns
When evaluating WayPoint Biomedical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of WayPoint Biomedical pink sheet have on its future price. WayPoint Biomedical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, WayPoint Biomedical autocorrelation shows the relationship between WayPoint Biomedical pink sheet current value and its past values and can show if there is a momentum factor associated with investing in WayPoint Biomedical Holdings.
Other Information on Investing in WayPoint Pink Sheet
WayPoint Biomedical financial ratios help investors to determine whether WayPoint Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in WayPoint with respect to the benefits of owning WayPoint Biomedical security.